Cellcure Cancer Centre Private Limited - Company Profile

It is a healthcare private limited company based in Borivali West, Maharashtra, India, established in 2017.
2017 Borivali West, Maharashtra, India Active
Last Updated:
Access Report
About Cellcure Cancer Centre Private Limited

Cellcure Cancer Centre Private Limited, a active private limited company, was established on 25 October 2017 in Borivali West, Maharashtra, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U74999MH2017PTC301138. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.57 Cr and a paid-up capital of ₹1.58 Cr.

It upholds a compliant status. Employing 354 professional, Its leadership includes Mayank Khanduja (Director), Vashista Pankaj Maniar (Director), Bhavin Ashokbhai Shah (Director). Past directors included Mayank Khanduja, Vashista Pankaj Maniar, Bhavin Ashokbhai Shah. It holds no open charges and ₹2.30 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1St & 2Nd Floor, Shree Saraswati Apartments, Chsl, Opposite Bhagwati Hospital, S.V. Road, Borivali West, Maharashtra, 400092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2017PTC301138

  • Registration Number

    301138

  • Incorporation Date

    25 October 2017

  • Authorized Capital

    ₹3.57 Cr

  • Paid-Up Capital

    ₹1.58 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.57 Cr
  • Paid Up Capital ₹ 1.58 Cr
  • Company Age 8 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 2.30 Cr
  • Revenue Growth **** 160.16%
  • Profit Growth **** 101.96%
  • Ebitda **** 97.72%
  • Net Worth 24.72%
  • Total Assets **** 11.13%
Company report

Cellcure Cancer Centre Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cellcure Cancer Centre Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cellcure Cancer Centre Private Limited?
Current Directors
Name Designation Appointment Date Status
Mayank Khanduja Director 13 Mar 2025 Current
Vashista Pankaj Maniar Director 25 Oct 2017 Current
Bhavin Ashokbhai Shah Director 24 May 2024 Current
Ashish Anand Joshi Director 25 Oct 2017 Current
Kshitij Chandrakant Joshi Director 25 Oct 2017 Current
Preetam Baban Kalaskar Director 25 Oct 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 13 Mar 2025 Past
Pramod Abcsdd Director 31 Mar 2021 Past
Pramod Abcsdd Additional Director 24 May 2024 Past
Pramod Abcsdd Director 27 Apr 2021 Past
Pramod Abcsdd Director 27 Apr 2021 Past
Pramod Abcsdd Director 27 Apr 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cellcure Cancer Centre.

Cellcure Cancer Centre Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 160.16% increase. The company also saw a substantial improvement in profitability, with a 101.96% increase in profit. The company's net worth Soared by an impressive increase of 24.72%.

Cellcure Cancer Centre revenue growth over time
Cellcure Cancer Centre profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 160.16%
*******
*******
*******
*******
Revenue from Operations
*******
 155.56%
*******
*******
*******
*******
Total Assets
*******
 11.13%
*******
*******
*******
*******
Profit or Loss
*******
 101.96%
*******
*******
*******
*******
Net Worth
*******
 24.72%
*******
*******
*******
*******
EBITDA
*******
 97.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cellcure Cancer Centre?

In 2024, Cellcure Cancer Centre had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹23,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 2.30 Cr
Latest Charge Details
Date Lender Amount Status
15 Nov 2022 Hdfc Bank Limited ₹2.30 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cellcure Cancer Centre?

Cellcure Cancer Centre has a workforce of 354 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cellcure Cancer Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellcure Cancer Centre's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cellcure Cancer Centre
Recent Activity within the Organization
  • Director Appointment

    The activity Visalakshi Chandramouli was appointed as a Additional Director was appointed as a Additional Director on 29 Nov 2025 & has been associated with this company since 3 months 9 days . was completed.

  • Annual General Meeting

    Progress on Cellcure Cancer Centre Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Cellcure Cancer Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Mayank Khanduja was appointed as a Director was appointed as a Director on 13 Mar 2025 & has been associated with this company since 11 months 26 days . was documented.

  • Charges

    A charge registered on 15 Nov 2022 via Charge ID 100651004 with Hdfc Bank Limited was fully satisfied on 31 Jul 2024. was recorded as a recent event.

  • Director Appointment

    Progress on Bhavin Ashokbhai Shah was appointed as a Director was appointed as a Director on 24 May 2024 & has been associated with this company since 1 year 9 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cellcure Cancer Centre Private Limited?

The CIN of Cellcure Cancer Centre Private Limited is U74999MH2017PTC301138.

Where is Cellcure Cancer Centre Private Limited headquartered?

Cellcure Cancer Centre Private Limited is headquartered at 1St & 2Nd Floor, Shree Saraswati Apartments, Chsl, Opposite Bhagwati Hospital, S.V. Road, Borivali West, Maharashtra, 400092.

When was Cellcure Cancer Centre Private Limited incorporated?

Cellcure Cancer Centre Private Limited was incorporated on 25 October 2017.

Who are the current directors of Cellcure Cancer Centre Private Limited?

The current directors of Cellcure Cancer Centre Private Limited are

What is the primary industry of Cellcure Cancer Centre Private Limited?

The primary industry of Cellcure Cancer Centre Private Limited is Hospital And Medical Care.

Is Cellcure Cancer Centre Private Limited a listed company?

Cellcure Cancer Centre Private Limited is unlisted.

What is the capital structure of Cellcure Cancer Centre Private Limited?

The authorized capital of Cellcure Cancer Centre Private Limited is ₹3.57 Cr, and the paid-up capital is ₹1.58 Cr.

What is the compliance status of Cellcure Cancer Centre Private Limited?

The compliance status of Cellcure Cancer Centre Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available